University of Delaware
Millicent Sullivan, PhD, is the Alvin B. and Julie O. Stiles Professor and Department Chair in Chemical & Biomolecular Engineering, and a Professor in Biomedical Engineering at University of Delaware. Millie graduated from Princeton University with a B.S.E. degree in Chemical Engineering and a Certificate in Engineering Biology in 1998. Subsequently, she attended Carnegie Mellon University as a Clare Boothe Luce Graduate Fellow, where she earned her Ph.D. degree in Chemical Engineering with Professor Todd Przybycien in 2003. As a Ruth L. Kirchstein NIH postdoctoral fellow, Millie worked with Professor E. Helene Sage in the Matrix Biology/Hope Heart Program of the Benaroya Research Institute. In 2006, Millie moved to the University of Delaware. Her laboratory develops new biomaterials for drug delivery, gene delivery, and tissue engineering, with therapeutic targets including wound healing, breast cancer, and pulmonary gene delivery. Specific fundamental foci include de novo peptide design, peptide and polymer self-assembly, and subcellular processing mechanisms. Sullivan is a member of the Penn Center for Targeted Therapeutics and Translational Nanomedicine (CT3N), and an Affiliate Member of the Delaware Biotechnology Institute. She is an AIMBE fellow, past Standing Member of the Gene and Drug Delivery (GDD) study section at NIH, and Honorary Professor of Chemical Engineering at the University of Melbourne, and she has been the recipient of awards and honors including a Fulbright Future Award, the Centennial Professorship, the NSF CAREER Award, and the Merck Faculty Fellow Award.
S15.4- Peptide-enabled Strategies for Intracellular Delivery of Gene Therapies
Friday, September 27, 2024
2:30 PM – 4:30 PM ET